Health-Chem Corporation
OTC: HCLC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ronald J. Burghauser
- Employees
- 55
- Headquarters
- Emigsville, United States
- IPO year
- 1972
- Market cap
- $74.0K
Loading HCLC…
Loading profile data…Frequently asked questions about HCLC
What does Health-Chem Corporation (HCLC) do?
Health-Chem Corporation, operating through its subsidiary, Transderm Laboratories Corporation, specializes in the research, development, manufacturing, and commercialization of transdermal drug delivery systems throughout the United States. Among its key products are transdermal nitroglycerin patches, formulated to provide relief for vascular an...
Where does HCLC trade?
Health-Chem Corporation (HCLC) trades on the Other OTC.
What sector is HCLC in?
Health-Chem Corporation (HCLC) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Health-Chem Corporation?
Ronald J. Burghauser is the chief executive officer of Health-Chem Corporation (HCLC).
Where is Health-Chem Corporation headquartered?
Health-Chem Corporation is headquartered in United States.
Does HCLC pay a dividend?
Health-Chem Corporation (HCLC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HCLC go public?
Health-Chem Corporation (HCLC) completed its initial public offering in 1972.